Trial Profile
Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Mar 2022
Price :
$35
*
At a glance
- Drugs Copper histidine (Primary)
- Indications Menkes kinky hair syndrome
- Focus Registrational; Therapeutic Use
- 21 Mar 2022 According to a Fortress Biotech media release, data from this study will be presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting.
- 08 Oct 2021 According to a Cyprium Therapeutics media release, data (n=129) from this study were presented at the virtual poster at the 2021 American Academy of Pediatrics National Conference & Exhibition.
- 08 Oct 2021 Results presented in a Cyprium Therapeutics media release.